Genetic toxicology of 1,1,2-trichloroethylene

Mutat Res. 1989 Jul;221(1):11-37. doi: 10.1016/0165-1110(89)90043-2.

Abstract

1,1,2-Trichloroethylene (TCE) is a widely used halogenated solvent, produced in hundreds of millions of kg each year for industrial purposes. Occupational and environmental exposure of human populations to TCE has been reported in industrialized areas. Long-term carcinogenicity studies in rodents demonstrate that exposure to high doses of TCE results in the induction of liver and lung tumors in the mouse, and tumors of the kidney and the testis in the rat. An indirect mechanism, based on the stimulation of liver peroxisome proliferation by TCE metabolites, was proposed to explain species differences in TCE hepatocarcinogenicity. Mutagenicity studies indicate that TCE is weakly active both in vitro, where liver microsomes produce electrophilic TCE metabolites, and also in vivo in mouse bone marrow, where high rates of micronuclei, but no structural chromosome aberrations, are found. Among TCE metabolites, trichloroacetic acid was reported to be carcinogenic to mouse liver. Furthermore, both trichloroacetic acid and chloral hydrate were found to be genotoxic in vivo, inducing structural and numerical chromosome abnormalities, respectively.

Publication types

  • Review

MeSH terms

  • Animals
  • Biotransformation
  • Carcinogens* / pharmacokinetics
  • Humans
  • Mutagenicity Tests
  • Mutagens* / pharmacokinetics
  • Solvents
  • Teratogens / pharmacokinetics
  • Trichloroethylene / pharmacokinetics
  • Trichloroethylene / toxicity*

Substances

  • Carcinogens
  • Mutagens
  • Solvents
  • Teratogens
  • Trichloroethylene